Abdelmalik Slassi
Patrimonio netto: 79 500 $ in data 30/09/2026
Patrimonio netto: 79 500 $ in data 30/09/2026
Abdelmalik Slassi was the founder of Mindset Pharma, Inc., founded in 2019, holding the title of Senior Vice President-Innovation.
Dr. Slassi is also the founder of Fluorinov Pharma, Inc...
Dr. Slassi is currently Director at Pharmala Biotech, Inc. Former positions include Director & Vice President-Medicinal Chemistry at NPS Pharmaceuticals, Inc., Independent Director at Pharmala Biotech Holdings, Inc. from 2021 to 2026, Director & VP-Manufacturing & Drug Development at Cascade Therapeutics, Inc., and Senior Vice President-Drug Discovery Research at Trillium Therapeutics, Inc. from 2016 to 2019.
Education includes a doctorate from Université Claude Bernard Lyon 1.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/05/2025 | 500.000 ( 0,46% ) | 79 500 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Direttore/Membro del Consiglio | 09/02/2026 |
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 01/12/2019 |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Fondatore | 01/01/2016 |
| MINDSET PHARMA INC. | Fondatore | - |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Commercial Services |
Mindset Pharma, Inc.
Mindset Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for psychiatric and neurological disorders | Health Technology |
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale